Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2024-06-03–present
Gayle Deflin
Board Member
Amphastar Pharmaceuticals, Inc. (AMPH)Equibles does not estimate personal net worth.
Get an email with a short summary when Amphastar Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMPH alertsAbout Gayle Deflin
Gayle Deflin is recorded as Board Member at Amphastar Pharmaceuticals, Inc. (AMPH) since June 3, 2024. Amphastar Pharmaceuticals, Inc. reported in an 8-K filed June 4, 2024 that Gayle Deflin was appointed Class II director, effective June 3, 2024. Amphastar Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amphastar Pharmaceuticals, Inc. includes Jack Yongfeng Zhang (CEO and Board Member), William J. Peters (CFO and Board Member), William Peters (CFO) and 7 others.
“Each director nominee was duly elected to serve until the 2027 annual meeting of stockholders and until his or her successor is duly elected and qualified.”
Affiliation history
-
Current
2024-06-03–present
Company network
Leadership on record at Amphastar Pharmaceuticals, Inc.
- Jack Yongfeng Zhang CEO, Board Member
- William J. Peters CFO, Board Member
- William Peters CFO
- Mary Ziping Luo COO, Board Member
- Jason B. Shandell General Counsel
- Anthony Pierce Board Member
- David Gaugh Board Member
- Howard Lee Board Member
- Jacob Liawatidewi Board Member
- Michael A. Zasloff Board Member